Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015', http://bit.ly/29QFXPp


In this issue


Home Eurosurveillance Edition  2014: Volume 19/ Issue 41 Article 6
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 19, Issue 41, 16 October 2014
News
First European guidelines on syndromic surveillance in human and animal health published
  1. Public Health Agency of Sweden, Stockholm, Sweden

Citation style for this article: Hulth A. First European guidelines on syndromic surveillance in human and animal health published. Euro Surveill. 2014;19(41):pii=20927. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20927

On 11 October 2014, the first European guidelines on syndromic surveillance in human and animal health, the ‘Triple-S guidelines for designing and implementing a syndromic surveillance system’, were published [1].The guidelines are one of the main outcomes of the European Union (EU) –funded project ‘Triple-S’, which main aim has been to increase the European capacity for near-real time surveillance and monitoring of health-related events in the animal and the human health sectors.

The Triple-S guidelines provide evidence-based recommendations and suggestions for each step of the set-up, use and assessment of a syndromic surveillance system. They aim to encourage a common understanding of the structure and utility of systems, and improve communication among European countries on critical public health threats. The guidelines are designed to be useful in the context of the wide range of health systems and data sources found in European countries, and their main principles can be applied globally. The guidelines are intended for public health professionals and epidemiologists working in human or animal health surveillance who would like to use syndromic surveillance to support existing surveillance systems and public health monitoring.

Triple-S was a project co-financed by the EU through the Executive Agency for Health and Consumers. It started in September 2010 and formally ended in December 2013, and was coordinated by the French Institute for Public Health Surveillance (InVS) in Paris. It involved twenty four organisations from thirteen European countries. As an outcome of the first meeting, held in November 2010, an updated definition of ‘syndromic surveillance’ was published in 2011 [2].

All publications originating from the Triple-S project, including the guidelines and reports on conducted inventories and site visits, can be found on the Triple-S web site.


References

1. Triple-S. The syndromic surveillance project. Triple-S; Oct 2014. Available from: http://www.syndromicsurveillance.eu/
2. Triple S Project. Assessment of syndromic surveillance in Europe. Lancet, 2011;378(9806):1833-4.
 



Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.